Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial by Huber, Rudolf M., Hansen, Karin H., Paz-Ares Rodríguez, Luis, West, Howard L., Reckamp, Karen L., Leighl, Natasha B., Tiseo, Marcello, Smit, Egbert F., Kim, Dong-Wan, Gettinger, Scott N., Hochmair, Maximilian J., Kim, Sang-We, Langer, Corey J., Ahn, Myung-Ju, Kim, Edward S., Kerstein, David, Groen, Harry J.M., Camidge, D. Ross

Get full text

Targeting EGFR in Lung Cancer: Current Standards and Developments by Díaz-Serrano, Asunción, Gella, Pablo, Jiménez, Elisabeth, Zugazagoitia, Jon, Paz-Ares Rodríguez, Luis

Get full text

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial by Smit, Egbert F, Felip, Enriqueta, Uprety, Dipesh, Nagasaka, Misako, Nakagawa, Kazuhiko, Paz-Ares Rodríguez, Luis, Pacheco, Jose M, Li, Bob T, Planchard, David, Baik, Christina, Goto, Yasushi, Murakami, Haruyasu, Saltos, Andreas, Pereira, Kaline, Taguchi, Ayumi, Cheng, Yingkai, Yan, Qi, Feng, Wenqin, Tsuchihashi, Zenta, Jänne, Pasi A

Get full text

Targeting EGFR in Lung Cancer: Current Standards and Developments by Díaz-Serrano, Asunción, Gella, Pablo, Jiménez, Elisabeth, Zugazagoitia, Jon, Paz-Ares Rodríguez, Luis

Get full text

Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study by Pujol, Jean-Louis, Vansteenkiste, Johan, Paz-Ares Rodríguez, Luis, Gregorc, Vanesa, Mazieres, Julien, Awad, Mark, Jänne, Pasi A., Chisamore, Michael, Hossain, Anwar M., Chen, Yanyun, Beck, J. Thaddeus

Get full text

Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase... by Thatcher, Nicholas, Goldschmidt, Jerome H, Thomas, Michael, Schenker, Michael, Pan, Zhiying, Paz-Ares Rodriguez, Luis, Breder, Valery, Ostoros, Gyula, Hanes, Vladimir

Get full text

Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials by Gettinger, Scott N., Huber, Rudolf M., Kim, Dong-Wan, Bazhenova, Lyudmila, Hansen, Karin Holmskov, Tiseo, Marcello, Langer, Corey J., Paz-Ares Rodríguez, Luis G., West, Howard L., Reckamp, Karen L., Weiss, Glen J., Smit, Egbert F., Hochmair, Maximilian J., Kim, Sang-We, Ahn, Myung-Ju, Kim, Edward S., Groen, Harry J.M., Pye, Joanna, Liu, Yuyin, Zhang, Pingkuan, Vranceanu, Florin, Camidge, D. Ross

Get full text

Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients by Carrato Mena, Alfredo, Paz-Ares Rodríguez, Luis, Rodríguez Lescure, Álvaro, Casas Fernández de Tejerina, Ana M., Díaz Rubio García, Eduardo, Pérez Segura, Pedro, Constenla Figueiras, Manuel, García Carbonero, Rocío, Gómez Codina, José, Lluch Hernández, Ana, Maroto Rey, José Pablo, Martín Jiménez, Miguel, Mayordomo Cámara, José Ignacio, Moreno Nogueira, José Andrés, Rueda Domínguez, Antonio

Get full text

716 Phase 2 study of the HER2-targeting TLR7/8 immune stimulating antibody conjugate (ISAC) BDC-1001 monotherapy +/- nivolumab in patients with HER2+ colorectal, endometrial, or ga... by Dumbrava, Ecaterina, Mestres, Joan Albanell, Ascierto, Paolo Antonio, Blay, Jean-Yves, Champiat, Stéphane, Salgado, Alfonso Cortes, Deleuze, Antoine, GilMartin, Marta, Heeke, Arielle, Italiano, Antoine, Kang, Yoon-Koo, Lee, Jeeyun, Lee, Keun-Wook, Losurdo, Agnese, Magni, Michele, Moore, Kathleen, Benzaquen, Ana Oaknin, Zabalza, Ignacio Ortego, Park, Haeseong, Rodriguez, Luis Paz-Ares, Pegram, Mark D, Ponz-Sarvise, Mariano, Rasco, Drew, Sharma, Manish, Shergill, Ardaman, Spano, Jean-Philippe, Spira, Alexander I, Vicier, Cecile, Victoria, Ivan, Weinberg, Benjamin, Tapia, Coya, Ptacek, Jason, Alonso, Michael N, Xu, Lu, Yin, Ming, Perez, Edith A, Li, Bob T

Get full text

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study by Garassino, Marina Chiara, Kim, Joo-Hang, Corral Jaime, Jesus, Powderly, John, Bidoli, Paolo, Wheatley-Price, Paul, Park, Keunchil, Wadsworth, Catherine, Dennis, Phillip A, Rizvi, Naiyer A, Paz-Ares Rodriguez, Luis, Novello, Silvia, Hiret, Sandrine, Schmid, Peter, Laack, Eckart, Califano, Raffaele, Vicente Baz, David, Berghmans, Thierry, Kim, Dong-Wan, Surmont, Veerle, Reck, Martin, Han, Ji-Youn, Holgado Martin, Esther, Chella, Antonio, Chopra, Akhil, Robinet, Gilles, Soto Parra, Hector, Thomas, Michael, Katakami, Nobuyuki, Su, Wu-Chou, Kim, Young-Chul, Lee, Jong-Seok, Saka, Hideo, Milella, Michele, Ramos Garcia, Inmaculada, Sibille, Anne, Atagi, Shinji, Spaeth-Schwalbe, Ernst, Nishio, Makoto, Imamura, Fumio, Derijcke, Sofie, Maeda, Tadashi, Zylla, Dylan, Santoro, Armando, Uy, Ma. Noemi, Lucien Geater, Sarayut, Kowalski, Dariusz, Chen, Yuh-Min, Spigel, David, Chewaskulyong, Busyamas, Garcia Gomez, Ramon, Alvarez Alvarez, Rosa, Yang, Chih-Hsin, Denis, Fabrice, Sakai, Hiroshi, Canon, Jean-Luc, Scholz, Christian, Kemmotsu, Hirotsugu, Azuma, Koichi, Feld, Ronald, Jassem, Jacek, Kubota, Kaoru, Waterhouse, David, Coudert, Bruno, Mark, Zsuzsanna, Chang, Gee-Chen, Herzmann, Christian, Chaudhry, Arvind, Giridharan, Selvaraj, Hesketh, Paul, Boccia, Ralph, Iannotti, Nichola, Haigentz, Missak, Reynolds, John, Nakagawa, Kazuhiko, Sugawara, Shunichi, Tan, Eng Huat, Takeda, Koji, Mohn-Staudner, Andrea, Panwalkar, Amit, Daniel, Davey, Kobayashi, Kunihiko, Ladrera, Guia Elena Imelda, Coupkova, Helena, Havel, Libor, Singh, Joginder, Murakami, Shuji, Anderson, Ian, Iqbal, Mussawar, Torri, Vamsee, Juhasz, Erzsebet, Koubkova, Leona, Levy, Benjamin, Page, Ray, Crinò, Lucio, Einspahr, David, Hagenstad, Christopher, Juat, Necy, Overton, Lindsay, Szalai, Zsuzsanna

Get full text

Abstract 543: IL-11, a novel diagnostic biomarker for lung adenocarcinoma, is involved in lung cancer tumorigenesis by Márquez, Laura Ojeda, Sanz, Patricia Yagüe, Pinelo, Sonia Molina, Moya, Amancio Carnero, Sweet-Cordero, Alejandro, Rodríguez, Luis Paz-Ares, Sánchez, Irene Ferrer

Get full text

Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-b... by Thatcher, Nicholas, Goldschmidt, Jerome H, Thomas, Michael, Schenker, Michael, Pan, Zhiying, Rodriguez, Luis Paz-Ares, Breder, Valery, Ostoros, Gyula, Hanes, Vladimir

Get full text

Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized con... by Borghaei, Hossein, Langer, Corey J., Paz‐Ares, Luis, Rodríguez‐Abreu, Delvys, Halmos, Balazs, Garassino, Marina C., Houghton, Baerin, Kurata, Takayasu, Cheng, Ying, Lin, Jianxin, Pietanza, M. Catherine, Piperdi, Bilal, Gadgeel, Shirish M.

Get full text

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-l... by Rosell, Rafael, Dr, Carcereny, Enric, MD, Gervais, Radj, MD, Vergnenegre, Alain, Prof, Massuti, Bartomeu, MD, Felip, Enriqueta, MD, Palmero, Ramon, MD, Garcia-Gomez, Ramon, MD, Pallares, Cinta, MD, Sanchez, Jose Miguel, MD, Porta, Rut, MD, Cobo, Manuel, MD, Garrido, Pilar, MD, Longo, Flavia, MD, Moran, Teresa, MD, Insa, Amelia, MD, De Marinis, Filippo, MD, Corre, Romain, MD, Bover, Isabel, MD, Illiano, Alfonso, MD, Dansin, Eric, MD, de Castro, Javier, MD, Milella, Michele, MD, Reguart, Noemi, MD, Altavilla, Giuseppe, MD, Jimenez, Ulpiano, MD, Provencio, Mariano, MD, Moreno, Miguel Angel, MD, Terrasa, Josefa, MD, Muñoz-Langa, Jose, MD, Valdivia, Javier, MD, Isla, Dolores, MD, Domine, Manuel, MD, Molinier, Olivier, MD, Mazieres, Julien, Prof, Baize, Nathalie, MD, Garcia-Campelo, Rosario, MD, Robinet, Gilles, MD, Rodriguez-Abreu, Delvys, MD, Lopez-Vivanco, Guillermo, MD, Gebbia, Vittorio, MD, Ferrera-Delgado, Lioba, MD, Bombaron, Pierre, MD, Bernabe, Reyes, MD, Bearz, Alessandra, MD, Artal, Angel, MD, Cortesi, Enrico, MD, Rolfo, Christian, MD, Sanchez-Ronco, Maria, PhD, Drozdowskyj, Ana, PhD, Queralt, Cristina, PhD, de Aguirre, Itziar, PhD, Ramirez, Jose Luis, PhD, Sanchez, Jose Javier, Prof, Molina, Miguel Angel, PhD, Taron, Miquel, PhD, Paz-Ares, Luis, MD

Get full text

Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy by Serrano, Maria Jose, Garrido-Navas, Maria Carmen, Diaz Mochon, Juan Jose, Cristofanilli, Massimo, Gil-Bazo, Ignacio, Pauwels, Patrick, Malapelle, Umberto, Russo, Alessandro, Lorente, Jose A., Ruiz-Rodriguez, Antonio J., Paz-Ares, Luis G., Vilar, Eduardo, Raez, Luis E., Cardona, Andres F., Rolfo, Christian

Get full text

Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses o... by Cho, Byoung Chul, Abreu, Delvys Rodriguez, Hussein, Maen, Cobo, Manuel, Patel, Anjan J, Secen, Nevena, Lee, Ki Hyeong, Massuti, Bartomeu, Hiret, Sandrine, Yang, James Chih Hsin, Barlesi, Fabrice, Lee, Dae Ho, Ares, Luis Paz, Hsieh, Robert W, Patil, Namrata S, Twomey, Patrick, Yang, Xiaoying, Meng, Raymond, Johnson, Melissa L

Get full text

MicroRNA-dependent regulation of transcription in non-small cell lung cancer by Molina-Pinelo, Sonia, Gutiérrez, Gabriel, Pastor, Maria Dolores, Hergueta, Marta, Moreno-Bueno, Gema, García-Carbonero, Rocío, Nogal, Ana, Suárez, Rocío, Salinas, Ana, Pozo-Rodríguez, Francisco, Lopez-Rios, Fernando, Agulló-Ortuño, Maria Teresa, Ferrer, Irene, Perpiñá, Asunción, Palacios, José, Carnero, Amancio, Paz-Ares, Luis

Get full text

CD4 + tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts by Jiménez-Reinoso, Anaïs, Molero-Abraham, Magdalena, Cirauqui, Cristina, Blanco, Belén, Garrido-Martin, Eva M, Nehme-Álvarez, Daniel, Domínguez-Alonso, Carmen, Ramírez-Fernández, Ángel, Díez-Alonso, Laura, Nuñez-Buiza, Ángel, González-Murillo, África, Tobes, Raquel, Pareja, Eduardo, Ramírez-Orellana, Manuel, Rodriguez-Peralto, José Luis, Ferrer, Irene, Zugazagoitia, Jon, Paz-Ares, Luis, Álvarez-Vallina, Luis

Get full text

CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials by Segal, Neil H., Melero, Ignacio, Moreno, Victor, Steeghs, Neeltje, Marabelle, Aurelien, Rohrberg, Kristoffer, Rodriguez-Ruiz, Maria E., Eder, Joseph P., Eng, Cathy, Manji, Gulam A., Waterkamp, Daniel, Leutgeb, Barbara, Bouseida, Said, Flinn, Nick, Das Thakur, Meghna, Elze, Markus C., Koeppen, Hartmut, Jamois, Candice, Martin-Facklam, Meret, Lieu, Christopher H., Calvo, Emiliano, Paz-Ares, Luis, Tabernero, Josep, Argilés, Guillem

Get full text

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemis... by Conde, Esther, Suárez-Gauthier, Ana, Benito, Amparo, Garrido, Pilar, García-Campelo, Rosario, Biscuola, Michele, Paz-Ares, Luis, Hardisson, David, de Castro, Javier, Camacho, M Carmen, Rodriguez-Abreu, Delvys, Abdulkader, Ihab, Ramirez, Josep, Reguart, Noemí, Salido, Marta, Pijuán, Lara, Arriola, Edurne, Sanz, Julián, Folgueras, Victoria, Villanueva, Noemí, Gómez-Román, Javier, Hidalgo, Manuel, López-Ríos, Fernando

Get full text